Physician profile
Robert A Benson
NPI 1962442954
$723.81
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $60.07 · 2021: $501.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $299.91 | 2021 | |
| Merck Sharp & Dohme LLC | $85.65 | 2021 | |
| Pfizer INC. | $82.96 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $71.64 | 2021 | |
| Astellas Pharma US INC | $63.28 | 2019-2020 | |
| Medtronic Vascular, INC. | $22.26 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.36 | 2019 | |
| Edwards Lifesciences Corporation | $17.95 | 2019 | |
| Amgen INC. | $17.60 | 2019 | |
| Cardinal Health 200 LLC | $16.35 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $15.78 | 2021 | |
| Amarin Pharma, INC. | $12.07 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Benson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.